These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31002129)

  • 1. HCP5 promotes colon cancer development by activating AP1G1 via PI3K/AKT pathway.
    Yun WK; Hu YM; Zhao CB; Yu DY; Tang JB
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2786-2793. PubMed ID: 31002129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MEG3 promotes liver cancer by activating PI3K/AKT pathway through regulating AP1G1.
    Sun Y; Cao FL; Qu LL; Wang ZM; Liu XY
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1459-1467. PubMed ID: 30840267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LINC00657 promotes the development of colon cancer by activating PI3K/AKT pathway.
    Lei Y; Wang YH; Wang XF; Bai J
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6315-6323. PubMed ID: 30338799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
    Gao BB; Wang SX
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EHMT2 promotes the development of prostate cancer by inhibiting PI3K/AKT/mTOR pathway.
    Fan HT; Shi YY; Lin Y; Yang XP
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7808-7815. PubMed ID: 31599405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis.
    Liu ZB; Wang JA; Lv RQ
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1418-1427. PubMed ID: 30840262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA LINP1 functions as an oncogene in endometrial cancer progression by regulating the PI3K/AKT signaling pathway.
    Zhang XH; Li M; Kang YJ; Xie YQ; Cao YX
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6830-6838. PubMed ID: 31486482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Non-Coding RNA XLOC_006753 Promotes the Development of Multidrug Resistance in Gastric Cancer Cells Through the PI3K/AKT/mTOR Signaling Pathway.
    Zeng L; Liao Q; Zou Z; Wen Y; Wang J; Liu C; He Q; Weng N; Zeng J; Tang H; Fang R; Lei Z; Tang Z; Yang X; Cui S
    Cell Physiol Biochem; 2018; 51(3):1221-1236. PubMed ID: 30481766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXK1 promotes malignant progression of breast cancer by activating PI3K/AKT/mTOR signaling pathway.
    Li ZQ; Qu M; Wan HX; Wang H; Deng Q; Zhang Y
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9978-9987. PubMed ID: 31799667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of lncRNA FER1L4 suppresses the proliferation and migration of the hepatocellular carcinoma via regulating PI3K/AKT signal pathway.
    Wang X; Dong K; Jin Q; Ma Y; Yin S; Wang S
    J Cell Biochem; 2019 Apr; 120(4):6781-6788. PubMed ID: 30382631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HOTTIP participates in mammary cancer by promoting cell proliferation via PI3K/AKT pathway.
    Gao W; Wu XL; Li DZ; Liu HD
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4181-4187. PubMed ID: 30024606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LINC00963 promotes hepatocellular carcinoma progression by activating PI3K/AKT pathway.
    Wu JH; Tian XY; An QM; Guan XY; Hao CY
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1645-1652. PubMed ID: 29630107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LINC01170 promotes the progression of endometrial carcinoma by activating the AKT pathway.
    Zhang Z; Liu X; Xu H; Li P; Zeng T; Du W; Lu X
    J BUON; 2018; 23(6):1745-1752. PubMed ID: 30610803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of miR-605 promotes the proliferation and invasion of prostate cancer cells by up-regulating EN2.
    Zhou YJ; Yang HQ; Xia W; Cui L; Xu RF; Lu H; Xue Z; Zhang B; Tian ZN; Cao YJ; Xing ZY; Yin S; He XZ
    Life Sci; 2017 Dec; 190():7-14. PubMed ID: 28943214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA PICART1 inhibits cell proliferation by regulating the PI3K/AKT and MAPK/ERK signaling pathways in gastric cancer.
    Li JF; Li WH; Xue LL; Zhang Y
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):588-597. PubMed ID: 30720166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA LINC00628 overexpression inhibits the growth and invasion through regulating PI3K/Akt signaling pathway in osteosarcoma.
    He R; Wu JX; Zhang Y; Che H; Yang L
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5857-5866. PubMed ID: 30280767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway.
    Qiao X; Lv SX; Qiao Y; Li QP; Ye B; Wang CC; Miao L
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8630-8639. PubMed ID: 30575903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of siRNA-silencing of SALL2 gene on growth, migration and invasion of human ovarian carcinoma A2780 cells.
    Miao F; Zhang X; Cao Y; Wang Y; Zhang X
    BMC Cancer; 2017 Dec; 17(1):838. PubMed ID: 29228922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of long non-coding RNA MFI2 functions as an oncogenic role in cervical cancer progression.
    Qu B; Zhao AH; Nie XZ; Sui R; Du MM; Jiang L; Wang HL
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4680-4687. PubMed ID: 31210294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LINC00968 accelerates the progression of epithelial ovarian cancer via mediating the cell cycle progression.
    Yao N; Sun JQ; Yu L; Ma L; Guo BQ
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4642-4649. PubMed ID: 31210289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.